GIRISH K. MALHOTRA, P.E. 29150 Bryce Road, Pepper Pike, OH 44124
Tel: 216-288-6489; 216-292-0626, e-mail: girish@epcotint.com
CAREER SUMMARY
60 years’ experience in Specialty, Custom, Fine Chemicals, Pharmaceuticals, Intermediates, Corrosion Inhibitors, Dye Intermediates, Food Additives, Flavors and Fragrances, Custom Chemicals, Resins, Coatings, Self Adhesive Products and Digital Imaging businesses.
PROFESSIONAL EXPERIENCE AND ACCOMPLISHMENTS
· Scaling up new products and coating methodologies.
· Identified and outlined methods to achieve savings of about $1 million per year for an electronic chemical client.
· Quadrupled capacity and reduced manufacturing cost by 40% for fluoro-polymers and surfactants at minimal investment.
· Presented a technology that allows production of “colored liquids” without taking a sample “off-line” (traditional method) resulting in 15-25 % profitability improvement in GDP equivalent growth industries.
· Reduced batch cycle time at an operation by 80% using a commercially available non-conventional technology that is about 25% of the cost of conventional technology.
· Developed and commercialized trivalent chrome corrosion inhibitors.
· Completed a global corrosion inhibitor study for a global multinational chemical company. Identified cost reduction opportunities.
· Developed and optimized electroplating chemical processes saving 25% cost.
· Improved operating efficiency of a waste treatment plant by 40% without any investment
· Established global leadership by developing strategic alliances in digital imaging with 50% gross margin.
· Improved product development process to reduce time to market to three months from nine months for self-adhesive product line.
· Maximized global patent protection and coverage to achieve exclusive relationship with customers.
· Managed worldwide technology transfer for self-adhesives.
· Tracked and evaluated self-adhesive and digital imaging technologies and recommends business opportunities.
· Conceptualized and directed development of a single ply battery label with battery tester.
· Rationalized and reduced Dutch Boy Brands SKU’s by 14% and identified 30% SKU reduction without loss of any business.
· Conceived and commercialized a unique “convenience” home repair package for the retail market. Conducted due diligence to acquire pilot plant for Sherwin Williams.
· Devised decentralization plan for corporate and division research and development efforts.
· Tested and implemented equipment resulting in 25% lower re-labeling cost and higher quality paints.
· Conceptualized and demonstrated continuous paint manufacturing process producing consistent quality paint leading to raw material consolidation and lower cost.
· Conceptualized, developed, tested, and implemented a semi-continuous paint manufacturing process that reduced costs by 40%.
· Managed program to recycle obsolete paint to new products and other uses.
· Conceived technology for continuous production of emulsion latex, alkyd, polyester, epoxy, and phenolic resins. Developed chemistries and demonstrated process feasibility.
· Managed program to recycle obsolete paint to new products and other uses.
· Managed chemical plant profitability from -3.7% to 7% in two years, by improving productivity, and reducing manufacturing costs and inventories.
· Coordinated with Sales and Marketing to increase site revenue by $5 million in one year.
· Implemented processing changes to double resin capacity and reduced operating time by 40% without any investment.
· Reduced manufacturing cost of an antioxidant and saved $3.5 million.
· Reduced antioxidant cost by 30% and doubled capacity without any capital investment.
· Directed start-up of food grade antioxidant plant.
· Met 110% of manufacturing plan while operating at 85% of budget.
· Established quality circles; increased capacity without capital and saved over $500,000 per year.
· Increased chemical intermediate capacity by 75% with a $40,000 investment, adding $1 million per year to factory profit.
· Implemented Six Sigma type operating methods and procedures in 1979-80 to improve corrosion inhibitor product capacity and quality resulting in doubling business.
· Directed and provided support to Manufacturing to reduce cost, improve quality and capacity increase to meet increased market needs.
· Developed and commercialized new custom chemicals.
· Developed hydrocarbon emission standards for State of Illinois.
· Developed Air pollution permit system for State of Illinois.
· Designed ethylene plants for Exxon.
· Conceptualized ethylene production from petroleum residue.
POSITION, RESPONSIBILITIES AND TITLES
EPCOT International - Pepper Pike, OH 1996- Present
Privately held consulting company: improves manufacturing efficiencies, quality, promotes pollution prevention and strategic alliances; supply chain management; sources raw materials globally in Specialty, Pharmaceuticals, Fine Chemicals, Coatings, Resin and Textiles businesses.
President
Consultant US FDA: Pharmaceutical Science and Clinical Pharmacology Advisory Committee November 2011
MORGAN ADHESIVES CO. (MACtac) - Stow, OH 1991 – 1996
$400 million plus international division of Bemis Co., manufacturer of flexible packaging films and specialty coated pressure sensitive products.
Director, Corporate Research & Technology
THE SHERWIN-WILLIAMS COMPANY - Cleveland, OH 1973 – 1991
$3.2 billion dollar architectural, industrial, and automotive coatings company.
Consumer Division: $2.5 billion architectural and industrial coating producing division.
· Business Development Project Director (1987 - 1991)
· Director, Process Engineering (1985 - 1987)
· Plant Manager, Antioxidants and Resins - Fords, NJ (1983 - 1985)
· Technical Director, Antioxidants and Resins - Fords, NJ (1981 - 1983)
· Production Area Manager, Corrosion Inhibitors & Intermediates - Cincinnati, OH (1979-1981)
· Group Leader/Senior Process Engineer (1973 - 1979)
EPA, STATE OF ILLINOIS - Springfield, IL 1971 – 1973 Environmental Protection Engineer
EXXON - Florham Park, NJ 1968 – 1971
Process Engineer
PATENTS, PUBLICATIONS AND QUOTATIONS
1. US Patent # 4,269,987 issued on May 26, 1981
2. Numerous technology innovations disclosed and not filed to protect process inventions.
3. Malhotra, Girish: Continuous vs. Batch Manufacturing, Paint and Coatings Industry, February 1999, Pages 100-103
4. Malhotra, Girish: Viewpoint: The Coating Industry’s Challenge for the New Millennium, Modern Paint & Coatings, October 1999, Page 60
5. Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; The Color of Money: New technology helps improve coatings production efficiency and profitability, Modern Paint & Coatings, Feb. 2001, Page 22-24.
6. Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; In-line measurement and correction of Color and physical properties; 7th Nürnberg Coatings Conference, Nürnberg April 7-8, 2003 Page 581-593
7. Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; In-line measurement and correction of Color and physical properties; Symposium on Color and Appearance Instrumentation, April 15-16, 2003, Chicago, IL
8. Malhotra, Girish: Process Puzzler: Maintaining Pump Prime: De-gas the ammonia; Chemical Processing, May 2004, pg. 38
9. Malhotra, Girish: Process Puzzler: Take out Torque Slowly add fine powder: Chemical Processing, October 2004, pg. 50
10. Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; New Paradigm For Coating Manufacturing Processes; International Coatings Exposition October 25-29, 2004, Chicago, IL
11. Malhotra, Girish: Coating manufacturing processes: Yesterday, today and tomorrow, Jan 5, 2005 http://specialchem4coatings.com
12. Malhotra, Girish: Dispersion Equipment – an overview; March 2, 2005 http://www.specialchem4coatings.com/
13. Malhotra, Girish: Multicell Technology; Annual R&D Council and Operations Management Meeting for a major coating company; March 2005
14. Malhotra, Girish: Batch or a Continuous Process: A Choice; Pharmaceutical Processing, March 2005, Page 16
15. Malhotra, Girish: Process Puzzler: Stop Solvent losses; Chemical Processing, March 2005, Page 45
16. Malhotra, Girish: Process Puzzler: Choose a pump wisely: Chemical Processing
17. Malhotra, Girish: Volatile Organic Compounds (VOC) regulations and Coating Industry, May 2005 http://specialchem4coatings.com
18. Malhotra, Girish: Process Puzzler: Know when the end is near: Chemical Processing, June 2005, Page 39
19. Chemical Week India Looks to Ethical Drugs, June 15, 2005, Page 27 http://www.chemweek.com/inc/articles/t/2005/06/15/029.html
20. Malhotra, Girish, Less is More in API Process Development: Pharmaceutical Manufacturing, July/August 2005, Pages 50-51
21. Malhotra, Girish: Process Puzzler: Vanquish material variations: Chemical Processing, July 2005, Page 45
22. Malhotra, Girish: Process Puzzler: Remove the fatty oil first: Chemical Processing, August 2005, Page 54
23. Malhotra, Girish ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE, October 26, 2005 http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4187OPH2_01_Malhotra.ppt
24. Malhotra, Girish: API Manufacture-Simplification and PAT: Pharmaceutical Processing, November 2005, Pages 24-27
25. Malhotra, Girish: Process Puzzler: Prevent heat-exchanger plugging: Recycle concentrated solution: Chemical Processing, November 2005, Page 52
26. Malhotra, Girish: Simplification is Profitability: Pharmaceutical Technology, December 2005, Pages 14-16
27. Malhotra, Girish: Pharma’s Changing workforce, Pharmaceutical Manufacturing, November/December 2005, Page 11
28. Malhotra, Girish: Making sense of temperature sensing: Poor Mixing? Chemical Processing January 2006
29. Malhotra, Girish: Indian Firms Tear Into Overseas API Markets, Chemical Week February 15, 2006, Pg 27- 36.
30. Malhotra, Girish: Engineering, innovation, national well-being. Chemical Engineering March 2006 Page 8
31. Malhotra, Girish: Fine Chemical Failures. Chemical Week, May 17, 2006, Page 5
32. Malhotra, Girish: Pharma Intermediates: M&A Frenzy Takes Hold, Chemical Week May 31, 2006, Page 33
33. Malhotra, Girish: Process Puzzler: Boost the reliability of a solvent supply pump- Use eccentric reducers: Chemical Processing, May 2006
34. Malhotra, Girish: Process Puzzler: Uncovering cause of solid build-up- Look at the material balance: Chemical Processing, September 2006
35. Malhotra, Girish: Indian Firm First to Gain FDA Approval for Pharma Formulation Intermediate, Chemical Week, September 20, 2006, Page 52
36. Malhotra, Girish: Process Puzzler: Automation – a boost to morale: Chemical Processing, November 2006, Page 50
37. Malhotra, Girish: QBD: First Things First, Pharmaceutical Manufacturing, November/ December 2006, Page 9
38. Malhotra, Girish: Process Puzzler: Sticky Valve-Focus on heat tracing failure: Chemical Processing, January 2007, Page 52
39. Chemical Week: Pharma Manufacturers Chase Greener, Cost-Efficient Chemistries, February 7, 2007, Page 21, Week
40. Malhotra, Girish: QBD: Myth or Reality? Processing, February 2007, Pages 10-16
41. Malhotra, Girish: Process Puzzler: Quick fix needed! Eventually, do a redesign Chemical Processing, May 2007, Page 42
42. Malhotra, Girish: Can Pharma Learn From the Unfolding Gluten Contamination Story? Pharmaceutical Manufacturing, May 3, 2007
43. Malhotra, Girish: Big Pharma and Lessons From Detroit’s Big Three: Focus on API Manufacturing, Or Lose Your Edge to Offshore Generics, Pharmaceutical Manufacturing, May 16, 2007
44. Malhotra, Girish: Continuous Processes Maintain Profitability, Drug Discovery and Development, June 2007, Pages 30-31
45. Malhotra, Girish: Big Pharma: Who's Your Role Model, Toyota or Edsel? Pharmaceutical Manufacturing, June 2007, Page 40
46. Malhotra, Girish: Change is needed, GLG Group Analysis, July 16, 2007
47. Malhotra, Girish: Can Indian Pharmaceutical companies be a threat? GLG Analysis July 27, 2007
48. Malhotra, Girish: ICI a British Gem is sold GLG Group Analysis August 6, 2007
49. Malhotra, Girish: Concerns over Akzo buying ICI GLG Group Analysis August 20, 2007
50. Malhotra, Girish: Pharmaceuticals, Profitability through Simplicity, October 5, 2007
51. Malhotra, Girish: API (active pharmaceutical ingredient) and specialty chemical costs, Profitability through Simplicity, October 10, 2007
52. Malhotra, Girish: Is IT a Catalyst for India’s Drug Industry Growth? Pharmaceutical Manufacturing, October 9, 2007
53. Malhotra, Girish: Pharmaceutical buzzwords, Profitability through Simplicity, October 13, 2007
54. Malhotra, Girish: India's contribution to humanity, Profitability through Simplicity, October 24, 2007
55. Chemical Week: Green Chemistry October 24, 2007 pg.23-26 Chemical Week
56. Malhotra, Girish: Downsizing, Profitability through Simplicity, October, 27, 2007
57. Malhotra, Girish: Purchase Power Parity, Profitability through Simplicity, October 29, 2007
58. Malhotra, Girish: What is India? Profitability through Simplicity, November 3, 2007
59. Malhotra, Girish: Environmentalism, Technology and Human Life, Profitability through Simplicity, November 15, 2007
60. Malhotra, Girish: Things we know about drug prices but are afraid to ask, Profitability through Simplicity, November 19, 2007
61. Malhotra, Girish: Pharmaceuticals, Their Manufacturing Methods, Ecotoxicology, and Human Life Relationship, Pharmaceutical Processing, November 2007 Pg 18-23
62. Malhotra, Girish Personal Dose: A New Direction and Profit, Drug Discovery and Development, December 1, 2007
63. Chemical Week: Backlash in the Cards from Indian Plant Effluent Study? December 5, 2007 Page 31 Chemical Week
64. Malhotra, Girish: Year 2007 in Pharmaceuticals, Profitability through Simplicity, December 11, 2007
65. Malhotra, Girish: Dow potential acquisition GLG Group Analysis December 17, 2007
66. Malhotra, Girish: New approach to develop drugs GLG Group Analysis December 20, 2007
67. Malhotra, Girish: Challenges to Ethical and Generic Drug producers, Profitability through Simplicity, December 23, 2007
68. Malhotra, Girish: Conversation of ABC, Dec. 2007 Published by EPCOT International
69. Malhotra, Girish: Implementing QbD: A Step-by-Step Approach, Pharmaceutical Processing, February 2008 Pg 16-18
70. Malhotra, Girish: Is close good enough? Heparin fiasco, Profitability through Simplicity. February 14, 2008, GLG Group Analysis, March 5, 2008
71. Malhotra, Girish: Heparin and Quality by design, Profitability through Simplicity, February 26, 2008
72. Malhotra, Girish: Drug safety, side effects, FDA, and its challenges, Profitability through Simplicity, March 9, 2008
73. Malhotra, Girish: “Quality by Analysis” cannot compete against “Quality by Design”, Profitability through Simplicity, March 15, 2008
74. Malhotra, Girish, Heparin Contamination: effort to maximize profits?, Profitability through Simplicity, March 19, 2008 Malhotra, Girish: New Management style: New experiment in Management?, Profitability through Simplicity, March 23, 2008
75. Malhotra, Girish: Process Puzzler: Clarify a clogged caustic conundrum – Try Recirculation: Chemical Processing March 2008 pg. 41-42
76. Malhotra, Girish: Ranbaxy, AstraZeneca, Nexium and NEW opportunities, Profitability through Simplicity, April 16, 2008
77. Malhotra, Girish: Process Puzzler: Succeed through thick and thin – Maintain the temperature: Chemical Processing April 2008 pg. 45-47
78. Malhotra, Girish: Suzlon is having Teething Problem, GLG Group Analysis, April 22, 2008
79. Malhotra, Girish: Paint Cost can be reduced by manufacturing technology innovation, GLG Group Analysis April 23, 2008
80. Malhotra, Girish: Ranbaxy and Daiichi Sankyo relationship, Profitability through Simplicity, June 11, 2008
81. Malhotra, Girish: Pharmaceutical Manufacturing: Is it the antithesis of Creative Destruction? Pharmaceutical Manufacturing, July 2008
82. Malhotra, Girish: Opportunities for Private Equity firms in India GLG Group Analysis, July 4, 2008, Profitability through Simplicity, July 10, 2008
83. Malhotra, Girish: Opportunities for the Pharmaceuticals to improve their manufacturing technology, GLG Group Analysis, July 22, 2008
84. Malhotra, Girish: Reshuffling of the global pharmaceutical drug deck, Profitability through Simplicity, July 22, 2008
85. Malhotra, Girish: Pharmaceutical business strategy, GLG Group Analysis, August 7, 2008
86. Manufacturing: As Ranbaxy’s World Turns, So Does Generics Model July/August 2008 pg. 12-14
87. Malhotra, Girish: Pharmaceutical companies and their effort to improve profits, GLG Group Analysis,September 11, 2008
88. Malhotra, Girish: Ranbaxy citations can be an excellent opportunity, Profitability through Simplicity, September 17, 2008, GLG Group Analysis, September 18, 2008
89. Malhotra, Girish: Pharma Convergence: Challenges in Drug Development and Manufacturing Methods, CHEManager Europe 10/2008, September 18, 2008, pg. 26
90. Malhotra, Girish: API Manufacturing: A Road Map for Green Chemistry and Processes: pharmaQbD.com October 14, 2008
91. Malhotra, Girish: Is Pharma Consolidation on Horizon, GLG Group Analysis, October 28, 2008, Profitability through Simplicity, November 4, 2008
92. Malhotra, Girish: Process Puzzler: Quell a quality control confrontation- Improve the Design: Chemical Processing November 2008 pg. 40-42
93. Malhotra, Girish: APIs Simplicity by Design. A Low-tech Approach for Quality and Profitability, Mastering Process Chemistry, Philadelphia, November 17-19, 2008
94. Malhotra, Girish: Is Auto Bailout a prelude for others to ask for help and an admission of “lack of vision”? Profitability through Simplicity, November 23, 2008
95. Malhotra, Girish: Is "Creative Destruction" the way to go for the Pharmaceuticals? GLG Group Analysis, December 10, 2008, Profitability through Simplicity, December 12, 2008
96. Malhotra, Girish: Process Puzzler: Get out of the Soup, Chemical Processing, December 2008 pg. 28
97. Malhotra, Girish: Forget Bail Out or Hand Out - the Answer is Innovation and Conservation, Profitability through Simplicity, January 1, 2009, Chemical Week, January 9, 2009
98. Malhotra, Girish: ISP: A Hidden ‘Diamond in the Rough’ Chemical Week, Profitability through Simplicity, January 13, 2009
99. Malhotra, Girish: Pfizer/Wyeth and GSK/UCB GLG Group Analysis January 26, 2009
100. Malhotra, Girish: Commoditization of Drugs, Chemical Week, Profitability through Simplicity, February 4, 2009
101. Malhotra, Girish: Why Have the Fine and Specialty Chemical Sectors Been Moving from Developed Countries? Chemical Week, Profitability through Simplicity, February 9, 2009
102. Malhotra, Girish: Dow and ROH GLG Group Analysis February 9, 2009
103. Malhotra, Girish: Alphabet Shuffle: Moving From QbA to QbD - An Example of Continuous Processing, Pharmaceutical Processing, February 2009 pg. 12-13
104. Malhotra, Girish: A Fine Chemical Version of Chernobyl? Chemical Week, Profitability through Simplicity, February 26, 2009
105. Malhotra, Girish: Pfizer, Generics and Commoditization GLG Group Analysis March 3, 2009
106. Malhotra, Girish: Rx for Pharma, Chemical Engineering Progress, March 2009, Vol. 105, No. 3 Pg. 34-38
107. Malhotra, Girish: Global Fine/Specialty Chemical Industry and its Challenges, Profitability through Simplicity, March 5, 2009
108. Malhotra, Girish: The Challenge for Fine and Specialty Chemical Firms, Chemical Week, March 19, 2009
109. Malhotra, Girish: Pharmaceuticals and Return on Investment (ROI), 2009, Chemical Week, Profitability through Simplicity, March 26
110. Malhotra, Girish: The Nano: The New iPod of the Manufacturing Industry? March 27, 2009 Chemical Week, Profitability through Simplicity
111. Malhotra, Girish: Pharmaceuticals in Water, Profitability through Simplicity, April 24, 2009
112. Malhotra, Girish: The Art of API Process Simplification and Scale-Up leading to QBD, Quality by Design Conference, International Pharmaceutical Academy, Toronto, April 27, 2009
113. Malhotra, Girish Process Puzzler: Kayo a Cascade Control Complication Chemical Processing May 2009 Pg. 43
114. Malhotra, Girish: Process of Continuous Improvement and Pharmaceuticals, GLG Group AnalysisProfitability through Simplicity, June 1, 2009
115. Malhotra, Girish: What is Holding Back Quality by Design? Chemical Week, Profitability through Simplicity, June 15, 2009
116. Malhotra, Girish: Recycling Coatings: An Environmental and Business Opportunity, Chemical Week, Profitability through Simplicity, July 8, 2009
117. Malhotra, Girish: Hesitation In The Drive To A Continuous Pharmaceutical Manufacturing Process: Real or Imaginary? Pharmaceutical Processing, July 2009 pg. 12-15
118. Malhotra, Girish: Climate Change and its Impact on Industrial Production, Chemical Week, GLG Group Analysis, Chemical Processing, Profitability through Simplicity, August 3, 2009
119. Malhotra, Girish: Chemical Engineering: Understanding the Curriculum for Quality Manufacturing, Chemical Week, Chemical Processing, Profitability through Simplicity, August 5, 2009
120. Malhotra, Girish: A Pharmaceutical Challenge for Technocrats, Chemical Week, Chemical Processing, Profitability through Simplicity, August 21, 2009
121. Malhotra, Girish: Photographs, World Photographers Organization, Volume 1, August 2009 pages 6, 13, 14, 15
122. Malhotra, Girish: Fine Chemicals: Quality Manufacturing and Technology Innovation in Pharmaceuticals, Chemical Week, Profitability through Simplicity, September 25, 2009
123. Chemical Week, Cost Cutting Becomes the Pharma Industry’s Mantra Chemical Week, October 5, 2009 pg. 24-28
124. Malhotra, Girish: Understanding QbD Requires Basic Fundamentals http://blog.pharmtech.com/ October 13, 2009
125. Malhotra, Girish: Photographs, World Photographers Organization, Volume 2, October 2009 page 9
126. Malhotra, Girish: QBA and Elements of QBD, Quality by Design, Challenges of implementing QbD / PAT in the development of rugged and robust formulations, processes, and Approvals October 19-20, 2009, Somerset, NJ
127. Malhotra, Girish: Exploitation of QBA Elements for a Batch/ Continuous Process, Quality by Design, Challenges of implementing QbD / PAT in the development of rugged and robust formulations, processes, and Approvals October 19-20, 2009, Somerset, NJ
128. Malhotra, Girish: An Interpretation of U.S. FDA Guidance for Pharma Manufacture, Chemical Week, Profitability through Simplicity, October 19, 2009
129. Malhotra, Girish: Review of Continuous Process for Modafinil, Continuous Processing in the Chemical and Pharmaceutical Industry II, 2009 AIChE Annual Meeting, November 10, 2009,Nashville, TN.
130. Malhotra, Girish: Analysis of API (Omeprazole): My perspective, Poster Session: Pharmaceutical Engineering, 2009 AIChE Annual Meeting, November 11, 2009, Nashville, TN.
131. Malhotra, Girish: What is Jugaad - a New Management Fad from India? Chemical Week, Chemical Processing, Profitability through Simplicity, December 10, 2009
132. World Images Today, World Photographers Organization, December 2009, pg. 14, 19-21
133. Malhotra, Girish: A Radical Approach to Fine/Specialty API Manufacturing Chemical Week, Profitability through Simplicity, January 20, 2010
134. Malhotra, Girish: Pharmexcil to invite drug regulators from Africa for brand buildup GLG Group Analysis January 28, 2010
135. Malhotra, Girish: HIV Drug Availability and Potential Manufacturing Opportunities, Chemical Week, Profitability Through Simplicity, February 2, 2010
136. Malhotra, Girish: World Images Today February 2010, pg. 55
137. Malhotra, Girish: Pharmaceutical Costs, Technology Innovation, Opportunities and Reality, Pharmaceutical Processing February 2010 pg.. 20-24
138. Green Chemistry: Lighting Up New Pharma Pathways, Chemical Week March 15, 2010, pgs.. 21-23
139. Malhotra, Girish: Relationship between Big Pharmaceuticals and the Indian Pharmaceuticals, GLG Group Analysis March 15, 2010
140. Malhotra, Girish: Alternate Interpretation of Pharmaceutical TLAs: Three-letter Acronyms Chemical Week, Profitability through Simplicity, Pharmaceutical Processing, March 16, 2010
141. Malhotra, Girish: Sanofi-Aventis Expansion in India, GLG Analysis, March 23, 2010
142. Malhotra, Girish: Process Centricity is the Key to Quality by Design, Pharmaceutical Processing, Chemical Week, Profitability through Simplicity April 6, 2010
143. Malhotra, Girish: Webinar: Simplifying Coating Formulations for Easier Scale-up Webinar, www.specialchem.com April 27, 2010
144. Malhotra, Girish: Microscopic Examination of Indian Pharmaceutical Acquisitions by Multinational Companies, Profitability through Simplicity, Chemical Week, GLG Analysis, May 25, 2010
145. Malhotra, Girish: You’re the CEO: Can You Justify the Costs of These QbD Projects?www.pharmaqbd.com June 4, 2010
146. Malhotra, Girish: Pharmaceutical Reverse Payments and Lower Drug Costs: An Interesting Dilemma, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, July 21, 2010
147. Malhotra, Girish: The Path Towards Continuous Processing, Pharmaceutical Processing, August 2010, pgs. 16-20
148. Malhotra, Girish: Square Plug In A Round Hole: Does this Scenario Exist in Pharmaceutical? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, August 17, 2010
149. Malhotra, Girish: The Importance of Fundamentals, Pharmaceutical Processing, Profitability through Simplicity, Chemical Week, August 31, 2010
150. Malhotra, Girish: Are The Rules A Constraint to Innovation, Competition and A Cause of Adulterated Product? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, October 1, 2010
151. Chemical Week: Pharmaceuticals Counterfeiting Drives Change, Chemical Week, September 27/October 4, 2010 pgs. 48-50
152. Malhotra, Girish: QbA--> QbD Imagination and Creativity Challenge, 5th International Conference and Exhibition, Process Analytical Technologies in Organic Process R&D, November 2, 2010, Clearwater, Florida
153. Malhotra, Girish: Pharmaceutical Companies Can innovate If They Want to, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, October 15, 2010
154. Malhotra, Girish: Comments on PAT Article, Chemical Engineering, pg. 6, October 2010
155. Malhotra, Girish: Process Puzzler: Deal with a Decanter that C’ant, Chemical Processing, November 2010
156. Malhotra, Girish: Constructive Destruction in Pharmaceutical Industry, GLG Group Analysis, December 13, 2010
157. Malhotra, Girish: Mr. Claus, Tear Down These Walls! PharmaQbD.com, December 16, 2010, Pharmaceutical Manufacturing Page 10, January 2011
158. Malhotra, Girish: Chemical Process Simplification: Improving Productivity and Sustainability, ISBN: 978-0-470-48754-9, Hardcover, 282 pages, January 2011, John Wiley & Sons Inc.
159. Malhotra, Girish: Inefficiency in Fine Chemicals Manufacture Set to Grow, Chemical Week, February 1, 2011
160. Malhotra, Girish: Are Patents a Double-Edged Sword? Perspective Matters, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week February 8, 2011
161. Malhotra, Girish: Chapter “Simplified Process Development and Commercialization” in Quality by Design: From Theory to Practice co-published by Parental Drug Association and DHI Publishing© 2011 February 2011 available at www.pda.org
162. Malhotra, Girish: Strategies to Enhance API Manufacturing: Identifying inefficiencies and optimizing development through quality by design, Business Insights, London, UK March 2011
163. Malhotra, Girish: QbA-> QbD: An imagination and creativity challenge, Chemica OGGI/ Chemistry TODAY March/April 2011, Vol. 29 n.2, pg. 42-44.
164. Malhotra, Girish: P&G and Teva is a win-win and Herculean Challenge for Many, GLG Group Analysis, March 26, 2011
165. Malhotra, Girish: Pharmaceutical Consolidation in the Developed Countries, GLG Group Analysis, March 31, 2011
166. Malhotra, Girish: Information Challenges for Product, Process Development and Process Design: A Reality Check, Chemical Week, Profitability through Simplicity, Chemical Processing, Pharmaceutical Processing, April 11, 2011
167. Malhotra, Girish: Opportunities for the Indian Generic Pharmaceuticals, GLG Group Analysis, April 13, 2011
168. Malhotra, Girish: Pharmaceuticals start their drive to Consolidation, GLG Group Analysis, May 2, 2011
169. Malhotra, Girish: Who or What killed QbD? And is there hope for resuscitation? Pharmaceutical Processing, May 2011, pg. 10-14
170. Malhotra, Girish: Drug Prices: Food vs. Medicine - A Difficult Choice for Some, Pharmaceutical Processing, Profitability Through Simplicity, Chemical Week, June 17, 2011
171. Malhotra, Girish: Sun Pharmaceuticals Industries could show Pharma's new course, GLG Group Analysis, July 5, 2011
172. Malhotra, Girish: Pharmaceutical Quality: Is it a Company or Regulatory Responsibility? August 1, 2011, Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week
173. Malhotra, Girish: Big Pharma's (Pfizer) First BIG Volley Against Generics, GLG Group Analysis, August 4, 2011
174. Malhotra, Girish: Generic Drug Fees: A Fantastic Opportunity, August 17, 2011, Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week
175. Malhotra, Girish: Drug Shortages: Causes and Cures, October 13, 2011 Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week
176. Malhotra, Girish: Does the Pharmaceutical Industry Need a Steve Jobs? November 9, 2011 Profitability through Simplicity, Pharmaceutical Processing, Chemical Week
177. Malhotra, Girish: Drugs for Infectious Diseases, Funding and Opportunity, December 11, 2011, Profitability Through Simplicity, Chemical Week, Pharmaceutical Processing
178. Malhotra, Girish: Manufacturing can address the global disease crisis, G+ December 19, 2011
179. Pharmaceuticals: Asian Contract Manufacturers Pose Challenge to Western Firms, Chemical Week, pgs. 21-26, Feb6/13, 2012,
180. Malhotra, Girish: Neglected Tropical Disease Drugs: What are they Telling US About Innovation? March 7, 2012 Profitability through Simplicity, Pharmaceutical Processing, Chemical Week
181. Malhotra, Girish: Focus on Physical Properties To Improve Processes: Chemical Engineering, Vol. 119 No. 4 April 2012, pgs. 63-66
182. Malhotra, Girish: Can the Combination of Creative Destruction and “Steve Jobs Traits” Lead to a Pharma QbD Spring? April 16, 2012, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week
183. Malhotra, Girish: A Guide to QbD for APIs, Pharmaceutical Processing, Volume 27, No. 4 May 2012, pg. 46-49, Pharma Times November 2012 pg. 45-47
184. Malhotra, Girish: Financial Justification for QbD and Cost of Regulation Compliance Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, May 22, 2012
185. Malhotra, Girish: Is the New Terminology Going to Make the Pharmaceutical Processes Environmentally Friendly and Economic? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week June 4, 2012
186. Malhotra, Girish: Is Continuous Processing in Pharma’s Future? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, July 24, 2012
187. Malhotra, Girish: Are the Savings of $120-$150 Billion Worth Having? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, August 30, 2012
188. Malhotra, Girish: Patents: Should We Change Intellectual Property Model/Strategies? Profitability through Simplicity, Chemical Week, Pharmaceutical Processing, IPSTRATEGY.com October 5, 2012
189. Malhotra, Girish: Improving Global Affordability of HIV/AIDS Drugs Through Technology Innovation Profitability through Simplicity, Pharmaceutical Processing, Chemical Week October 19, 2012
190. Malhotra, Girish: Government of India’s Brand vs. Generics Tell of Today’s Conflicts and Reality Profitability through Simplicity, Pharmaceutical Processing November 15, 2012
191. Malhotra, Girish: The Op-Ed: Some Indian Drugmakers Need A Fix, www.Pharmalot.com January 9, 2013
192. Malhotra, Girish: Can Falsified Medicine and Other Directives Backfire? Profitability through Simplicity, Pharmaceutical Processing January 31, 2013
193. Malhotra, Girish: The Secret Life of APIs www.pharmaevolution.com February 26, 2013
194. Malhotra, Girish: The Secret Life of APIs: The Importance of Sociochemicology April 4, 2013
195. Malhotra, Girish: Sociochemicalogy, www.pharmaevolution.com April 9, 2013
196. Malhotra, Girish: Lost in Translation? - Can QbD Translate to Jobs in the Pharmaceutical Industry? Pharmaceutical Processing April 17, 2013
197. Malhotra, Girish: Product Volume & API Process Optimization, www.pharmaevolution.com May 2, 2013
198. Malhotra, Girish: Improving APIs & Formulation: Are You Harnessing the Power of Liquids? http://www.pharmaevolution.com May 14, 2013
199. Chemical & Engineering News Volume 91 Issue 21 pp. 30-31 May 27, 2013
200. Malhotra, Girish: Is it Time to Revamp cGMPs? http://www.pharmaevolution.com May 29, 2013
201. Malhotra, Girish: QbD: Its Value, Impact and Economics, Pharma-QbD Forum, June 12-14, 2013, The Lalit, Mumbai India
202. Malhotra, Girish: The Art of API Simplification and QbD based Manufacturing, Pharma-QbD Forum, June 12-14, 2013, The Lalit, Mumbai India
203. Malhotra, Girish: QbD on the Menu at CPhI Mumbai: Industry Savings of $200 Billion Possible, June 19, 2013, www.pharmaevolution.com
204. Malhotra, Girish: Can Clinton/Gates Save Pharma? www.pharmaevolution.com June 24, 2013
205. Malhotra, Girish: Letter to Indian Pharma CEOs: Have You Lost Your Chance to Innovate? www.pharmaevolution.com July 26, 2013
206. Malhotra, Girish: Increasing Profits by Reaching Pharma’s Silent Majority, http://www.pharmaevolution.com August 5, 2013
207. Malhotra, Girish: Shift to continuous process from batch and reap the benefits, Chemical Industry Digest, Vol.XXVI 8, August, 2013, pg. 7
208. Malhotra, Girish: Conflicts and opportunities in the Life of APIs, Chimica Oggi-Chemistry Today Vol. 31 (4) July/August 2013 pgs. 10-13
209. Malhotra, Girish: Imagine… a Process-Centered Pharma www.pharmaevolution.com September 11, 2013
210. Malhotra, Girish: Millions? Billions? Millions? Billions? A Matter of Perspective September 21, 2013 www.pharmaevolution.com
211. Malhotra, Girish: CPhI Pharma Evolution Annual Industry Report part 2, pgs. 22-25 October 2013
212. Malhotra, Girish: The Nail That Sticks Out Could Change the World: When Culture Stifles Innovation, www.pharmaevolution.com November 14, 2013
213. Malhotra, Girish: Break the Rag Layer, Chemical Processing Process Puzzler, November 2013, Page 50
214. Malhotra, Girish: Indian Producers have to Consider a Process Centric Model, www.pharma.financialexpress.com page 58, 61, November 2013
215. Malhotra, Girish: Could the Google Books Decision Set a Precedent for Global Pharma Patents? http://www.pharmaevolution.com December 10, 2013
216. Malhotra, Girish: Revamp the Process, Chemical Processing, Process Puzzler, December 2013 Page 32
217. Malhotra, Girish: Can Emerging Pharma's Leadership Move On to the Next Stage? www.pharmaevolution.com December 18, 2013
218. Malhotra, Girish: Reading the Tea Leaves: Predictions for Pharma's Future, www.pharmaevolution.com January 15, 2014
219. Malhotra, Girish: Will Pharma's Global Customers Redefine Maslow’s Hierarchy of Needs? www.pharmaevolution.com January 27, 2014
220. Malhotra, Girish: What Do The Recent Ranbaxy Citations Teach Us? Profitability through Simplicity, February 4, 2014
221. Malhotra, Girish: Safety and Safe Practices in Chemical Manufacturing, March 17, 2014 Presented at Cleveland State University Senior Class
222. Malhotra, Girish: Ranbaxy: Lessons and Opportunities, Contract Pharma, April 9, 2014, Contract Pharma, May, 2014 pg. 28-29
223. Malhotra, Girish: Sun Pharma’s Exotic Challenge: How Real?, Profitability through Simplicity, April 23, 2014
224. Malhotra, Girish: API Manufacturing’s Stuck in the Mud. Pharmaceutical Manufacturing, May 2014 pg. 42
225. Malhotra, Girish: Toward a Process-Centered Pharma, Contract Pharma, Vol.16, 5, Pg 46-48, June 2014
226. Malhotra, Girish: INJECT THE WAX AT THE PUMP, Chemical Processing, July 10, 2014
227. Malhotra, Girish: Why Fitting a Square Plug in a Round hole is Profitable for Pharma and Most Likely Will Stay? Profitability through Simplicity, Pharmaceutical Processing, August 1, 2014
228. Malhotra, Girish: Landscape Disrupters Are Becoming Part of the Pharma’s Playing Field, Profitability through Simplicity, August 17, 2014
229. Malhotra, Girish: Are Toyota’s manufacturing practices the right benchmark for the pharma? Chemica Oggi-Chemistry Today, Vol. 32(4), pg. 2-3,July/August 2014
230. Malhotra, Girish: A Blueprint for Improved Pharma Competitiveness, Contract Pharma, Vol. 16, 7, Pg. 46-49, September 2014
231. Malhotra, Girish: Is McLaren Going to be Pharma’s “Creative Destructionist”? Profitability through Simplicity, October 14, 2014
232. Malhotra, Girish: Regulatory Compliance vs. Operational Excellence: What Should Happen First? Profitability through Simplicity, February3, 2015
233. Malhotra, Girish: Compliance vs. Operational Excellence, Pharmaceutical Manufacturing, pg. 50, March 2015
234. Malhotra, Girish: Could Pharma’s New Movers and Shakers Make a Difference? Profitability through Simplicity, April 24, 2015
235. Malhotra, Girish: May Day May Day: Can Someone Help and Lower Drug Prices? Profitability through Simplicity, May 1, 2015
236. Malhotra, Girish: How to Justify Innovation and QbD in Manufacturing, Pharmaceutical Manufacturing, May 4, 2015 Pg. 35-36
237. Malhotra, Girish: Continuous Process in Pharmaceutical Manufacturing: Considerations, Nuances and Challenges, Contract Pharma, June 2, 2015
238. Malhotra, Girish: Can An Alliance Between US Pharmaceutical Benefit Managers (1) and Make in India (2) Lead to Lower Global Drug Prices?, Profitability through Simplicity, June 17, 2015
239. Malhotra, Girish: Are Software Technologies Going to be Pharma’s Creative Destructionists?, Profitability through Simplicity, July 14, 2015
240. Malhotra, Girish: Impact of 21CFR 314.70 on The Life of a Pharmaceutical Manufacturing Process, Profitability through Simplicity, August 7, 2015
241. Malhotra, Girish: Could Software Technologies be the “Creative Destructionist” for Pharmaceuticals and Chemicals?, Profitability through Simplicity, August 31, 2015
242. Malhotra, Girish: Manufacturing technologies and their part to achieve future pharmaceutical sales, Chemica Oggi Chemistry- Today, September/October 2015 Vol. 33(5) pg. 28-31
243. Malhotra, Girish: My perspective for Pharmaceutical Manufacturing Technologies/Processes and Continuous Improvements, CPhI 2015, http://epcotint.com/Pharmaevolution/GirishMalhotraSeptember2015CPhIreport.pdf
244. Malhotra, Girish: Is Pharma’s Goal to Serve Patients Per Billion or Million? Profitability through Simplicity October 2, 2015
245. Malhotra, Girish: Mitigate a Manager’s Mayhem: Go Back to Original Design, Chemical Processing, October 2015
246. Malhotra, Girish: Cleveland State University, Lecture to Two Senior Classes, Social Behavior of Chemicals, October 21, 2015
247. Malhotra, Girish: Calling for Change, Profitability through Simplicity, November 17, 2015
248. Malhotra, Girish: Is FDA Rule 21CFR314.70 a Case of “Shackled Freedom” for Pharmaceutical Manufacturing?, Profitability through Simplicity, Pharmaceutical Processing, November 19, 2015
249. Malhotra, Girish: Who Is/Or Should Be Driving Pharma’s Manufacturing Car: Regulators or the Regulated? Profitability through Simplicity, December 7, 2015
250. Malhotra, Girish: Pharma’s Landscape’s going to look a lot different in 2026 http://www.pharmamanufacturing.com/articles/2016/pharma-landscape-2026/ February 5, 2016
251. Malhotra, Girish: Continuous Pharmaceutical Processes and Their Demands, Contract Pharma, pg. 37-40, April 5, 2016
252. 252.Malhotra, Girish: Can Senate And House Bills S2615 And HR 4784 [Increasing Competition in Pharmaceuticals Act] Alter the Pharmaceutical Landscape?, Profitability through Simplicity, May 26, 2016
253. Malhotra, Girish: Pharmaceutical Process: Batch or Continuous Reality, Myth or Imagination, Contract Pharma: 2016 Contracting and Outsourcing Conference, New Brunswick, September 23, 2016
254. Malhotra, Girish: Manufacturing Processes Require Financial Justification, CPhI, September 26, 2016 pgs12-14
255. Malhotra, Girish: Manufacturing Processes Require Financial Justification, Contract Pharma, CPhI Annual Industry Report 2016: Expert Contribution, September 27, 2016
256. Malhotra, Girish: Financial Justification in Pharma, Pharmaceutical Manufacturing, Volume 15, Issue 9, November 4, 2016
257. Malhotra, Girish: Process Innovations: Who Should Lead & Their Impact?, Contract Pharma, November 9, 2016 Vol. 18 No. 9, pg. 69-71
258. Malhotra, Girish: Industry 4.0 (Digitization): Its Benefits to Pharma and Other Chemical Industries, Profitability through Simplicity, November 11, 2016
259. Malhotra, Girish: Opportunity to showcase excellence and drive forward industry standards: the CPhI Awards, Chemica Oggi-Chemistry Today, Vol 34(6), November/December 2016, pgs. 64-65
260. Malhotra, Girish: Develop A Dialog, Chemical Processing, December 2016, Vol. 78, Issue 12
261. Malhotra, Girish: Can Uniform Safety, Health and Effluent and Manufacturing Standards Create Process Technology Innovation and Competition in Pharmaceuticals? Profitability through Simplicity, January 10, 2017
262. Malhotra, Girish: Pharmaceutical Sales Forecasts: Fiction, Facts or Alternate Facts, Profitability through Simplicity, February 9, 2017
263. Malhotra, Girish: Manufacturing processes require financial justification, Chemica Oggi - Chemistry Today, Vol. 35 January/February 2017, pg. 38-39
264. Malhotra, Girish: Process Simplification and The Art of Exploiting Physical Properties, Profitability through Simplicity, March 10, 2017
265. Malhotra, Girish: Strategies for Improving Batch or Creating Continuous Active Pharmaceutical Ingredient (API) Manufacturing Processes, Profitability through Simplicity, March 20, 2017
266. Malhotra, Girish: Can the Review and Approval Process for ANDA at USFDA be Reduced from Ten Months to Three Months?, Profitability through Simplicity, March 25, 2017
267. Malhotra, Girish: Reality and Un-Reality: Continuous Processing in Pharmaceutical Manufacturing, Contract Pharma, April 3, 2017
268. Malhotra, Girish: Would The Coating Industry’s Consolidation Lead to Manufacturing Innovation? Profitability through Simplicity, April 26, 2017
269. Malhotra, Girish: ANDA (Abbreviated New Drug Application) / NDA (New Drug Applications) Filing Simplification: Road Maps are a Must., Profitability through Simplicity, May 11, 2017
270. Malhotra, Girish: Kudos For Research, Chemical Processing, June 2017, Pg 47
271. Malhotra, Girish: The Medicine Maker Issue #0617, Calling for ANDA Action, June 2017
272. Malhotra, Girish: Batch, Continuous or "Fake/False" Continuous Processes, Profitability through Simplicity, July 20, 2017, American Pharmaceutical Review, Vol. 20 Issue 6 September/October 2017 pgs. 86-91, Contract Pharma, Nov./Dec. 2017 pgs. 56-58, Chemistry Today, November/December 2017, Vol. 35(6) pgs. 62-65
273. Malhotra, Girish: An Alternate Look at the Pharmaceutical World Revenues and Drug Affordability, Pages 2-5, CPhI 2017 Annual Report, www.gmpnews.net, Autumn 2017, Manufacturing Chemist, Volume 88, Number 10, October 2017, Pg. 28-32
274. Malhotra, Girish: Innovation In Pharmaceuticals: What Would It Take & Who is Responsible?, Profitability through Simplicity, November 28, 2017
275. Malhotra, Girish: Pharmaceutical Manufacturing Technology Innovation: Does Reading the Tea Leaves Matter? Profitability through Simplicity, December 22, 2017
276. Malhotra, Girish: Forget About and Easy Fix, An Essential Question, Chemical Processing, December 2017, Pg 32
277. 277.Malhotra, Girish: Comparison of Drugs Prices: US vs. India; Their Manufacturing Costs & Opportunities to Improve Affordability, Profitability through Simplicity, January 18, 2018
278. Malhotra, Girish: Could Amazon (A), Berkshire Hathaway (B) and J.P. Morgan Chase (M) be the Anti Ballistic Missile (ABM) needed to Control/Curb Rising Healthcare Costs? Profitability through Simplicity, February 9, 2018: Healthcare Costs Run Rampant, Contract Pharma, March 2018, Vol. 20, No. 2 Pg 32-34
279. Girish Malhotra: Opportunities to Lower Drug Prices and Improve Affordability: From Creation (Manufacturing) to Consumption (Patient), Profitability through Simplicity, March 9, 2018, Contract Pharma, May 8, 2018, gmpnews.net, Pgs.44-47, No. 1(2) 2018
280. Malhotra, Girish: The Good, The Bad, and The Ugly1 Complexities of the Pharmaceutical Manufacturing, Profitability through Simplicity, April 9, 2018, Contract Pharma June 2018 Vol. 20 No.5
281. Video: Continuous Pharmaceutical Manufacturing: American Pharmaceutical Review, April 17, 2018
282. Malhotra, Girish: Learn Some Lessons, Chemical Processing, April, 2018 pg. 22
283. Continuous Processing Roundtable, American Pharmaceutical Review, https://www.americanpharmaceuticalreview.com/Continuous-Processing/, https://www.americanpharmaceuticalreview.com/Featured-Articles/349412-Continuous-Processing/, pgs. 54-58, April 2018
284. Malhotra, Girish: Improving Drug Affordability for the United States Populous through Alternate Business Models, Profitability through Simplicity, May 4, 2018; American Pharmaceutical Review, Vol 21 Issue 4, Pg. 12-14
285. Malhotra, Girish: Amazon PillPack Marriage can Alleviate Drug Shortages and May be Lower Drug Prices, Profitability through Simplicity, July 5, 2018
286. Malhotra, Girish: Pharma’s future is putting innovations in the hands of innovators, CPhI Annual Industry Report 2018, August 23, 2018, Contract Pharma, September 11, 2018 pgs. 30-34
287. Malhotra, Girish: Past, Present and Future in Pharmaceuticals, Profitability through Simplicity, October 5, 2018
288. Malhotra, Girish: A 20 Year Retrospective: The Pharmaceutical Industry Then and Now, American Pharmaceutical Review, October 15, 2018
289. Malhotra, Girish: Keeping Innovation in our Hands, Pharmaceutical Manufacturing, Pg. 42, October 2018
290. Malhotra, Girish: What Is Needed for a Regulatory Approval of NDA/ANDA Filings in 90 Days? Profitability through Simplicity, October 24, 2018
291. Malhotra, Girish: Quick Review of Chemicals Related Process Development, Design and Scale up Considerations, Profitability through Simplicity, November 7, 2018
292. Malhotra, Girish: Take a Cold-Eyed Look at a Cooling Problem, Chemical Processing, November 2018 pgs. 43
293. Malhotra, Girish: Simplified Roadmap for ANDA/NDA Submission and Approval will change Pharma Landscape, Profitability through Simplicity, November 25, 2018
294. Malhotra, Girish: Identifying the Root Causes of Drug Shortages and Finding An Enduring Solution,Profitability through Simplicity, December 7, 2018, Pharmaceutical Processing, December 10, 2018
295. Malhotra, Girish: Weigh The Cause Of Feeder Problems, Chemical Processing, pg.32, December, 2018
296. Malhotra, Girish: Set Up An Internal Team, Process Puzzler, Chemical Processing, February 2019
297. Malhotra, Girish: Impact of Regulations, Drug Manufacturing and Pharma Supply Chain (PBMs and allies) in Drug Shortages and Affordability, Profitability through Simplicity, March 8, 2019
298. Malhotra, Girish: Impact of Regulations, Manufacturing and Pharmaceutical Supply Chain (PBMs) on Drug Shortages and Affordability: Part 2: Profitability through Simplicity, April 3, 2019
299. Malhotra, Girish: Delve Deeper, Chemical Processing, April 9, 2019
300. Malhotra, Girish: Considerations to Simplify Organic Molecule (API) Manufacturing Processes: My perspective, Profitability through Simplicity, April 20, 2019
301. Malhotra, Girish: Opportunities for Generic Pharma to Clear the Quality Stigma, Profitability through Simplicity, May 23, 2019
302. Malhotra, Girish: Systematic Demystification of Drug Price Mystique and the Needed Creative Destruction, Profitability through Simplicity, October 2, 2019
303. Generics drive API growth, Chemical Week, September 23/30 2019, pgs. 32-34
304. Malhotra, Girish: Are USFDA 483 Citations a “Medal of Honor” or “Rite of Passage” to Disgrace for the Pharma companies? Profitability through Simplicity, October 16, 2019
305. Malhotra, Girish: Pharmaceutical Quality: Concepts, Misconceptions, Realities and Remedies, Profitability through Simplicity, November 4, 2019
306. Malhotra, Girish: Drug Shortages, Quality and Prices: Who is Responsible? Profitability through Simplicity, November 6, 2019
307. Malhotra, Girish: ONE PAGE Road Map to Reduce Drug Shortages, Assure Quality and Improve profitability, Profitability through Simplicity, December 6, 2019
308. Malhotra, Girish: Talk to the Vendor, Do Cranky Centrifuges Deserve Another Turn?, Chemical Processing, February 2020
309. Malhotra, Girish: Strategies to Increase Generic Drug Competition and Bring Manufacturing to The United States of America, Profitability through Simplicity, March 16, 2020
310. Malhotra, Girish: Focus on Quality, Remedy a Recalcitrant Reactor, Chemical Processing Process Puzzler, March 2020, pg. 36
311. Malhotra, Girish: GDFUA II ANDA (Abbreviated New Drug Application) Review Target of 8-10 Months should be a Cause of Concern, Profitability through Simplicity, March 24, 2020
312. Malhotra, Girish: How Would US FDA Behave/React if They Were on the Receiving End? Profitability through Simplicity, March 27, 2020
313. Malhotra, Girish: Long Term Drug Quality Supplies for US, FDA and A New Reality, Profitability through Simplicity, April 3, 2020
314. Malhotra, Girish: Quash Commissioning Quandaries, Fire THE CEO!, Chemical Processing, Process Puzzler, April 2020, pg. 34
315. Malhotra, Girish: Does A Double-Wall Tank Make Sense?, Answer Some Key Questions, Chemical Processing, May 2020
316. Malhotra, Girish: Health and National Security Issues for the USA and is The United States of America Prepared, Profitability through Simplicity, May 8, 2020
317. Malhotra, Girish: Euphoria to Bring Pharma Manufacturing Home to United States its Reality and Challenges, Profitability through Simplicity, May 23, 2020
318. Malhotra, Girish: Bring Pharmaceutical Manufacturing Back to USA: Additional Thoughts and Recap, Profitability through Simplicity, May 29, 2020
319. Malhotra, Girish: A road map for driving pharmaceutical manufacturing back to the USA by 2025, Profitability through Simplicity, October 8, 2020
320. Malhotra, Girish: Comment posted for Public Health Focused Essential Meds, MCM and Their Critical Inputs List to Address Section 3(c) of EO 13944(1)
321. Malhotra, Girish: Active Pharmaceutical Ingredient Manufacturing (API) and Formulation Drive to NET ZERO (Carbon Neutral)? Profitability through Simplicity, April 29, 2021
322. Malhotra, Girish: Climate Change and Greening of Pharmaceutical Manufacturing, Profitability through Simplicity, January 24, 2022
323. Malhotra, Girish: Ditch the Dryer, https://www.chemicalprocessing.com/articles/2022/powder-handling-dryer-revamp-demands-care February 13, 2022
324. Malhotra, Girish: Pharma’s Active Pharmaceutical Ingredient Manufacturing: Their Environmental Impact and Opportunities, Profitability through Simplicity, March 3, 2022
325. Malhotra, Girish: US’s Self Sufficiency for Generic Drugs: A Supply Dilemma and Potential Solutions, Profitability through Simplicity, March 31, 2022
326. Malhotra, Girish: Active Pharmaceutical Ingredient Manufacturing: Nondestructive Creation April 19, 2022 https://www.degruyter.com/document/doi/10.1515/9783110702842/html
327. Malhotra, Girish: Climate Change & greening of pharmaceutical manufacturing, Specialty Chemicals Magazine May/June 2022 pgs. 26-28
328. How can pharma achieve ‘Net Zero’? Through driving change in pharma manufacturing https://www.cphi-online.com/how-can-pharma-achieve-net-zero-through-driving-news117631.htmlMay 23, 2022
329. Malhotra, Girish: Has US lost its Business Acumen, Creativity and Imagination for its Healthcare Needs? Profitability through Simplicity, June 6, 2022
330. Malhotra, Girish: Sustainable API Manufacturing Podcast June 16, 2022
331. Malhotra, Girish: Amazon’s Opportunity to be a Generic Drug Player Profitability through Simplicity, August 2, 2022
332. Malhotra, Girish: Innovation in Pharmaceuticals Manufacturing Technologies, Distribution & Regulations: Are they Easy or a Challenge? Profitability through Simplicity September 26, 2022
333. Malhotra, Girish: API MANUFACTURING AND ENVIRONMENTAL SUSTAINABILITY Chemistry Today, September/October 2022 Vol. 40(5)
334. Malhotra, Girish: Comments & Feedback to USFDA on Distributed and POC Manufacturing FDA-2022-N-2316
335. Malhotra, Girish: Expert Opinion Flow Chemistry in Pharmaceutical Manufacturing. https://www.chemanager-online.com/en/news/expert-statement-girish-malhotra-epcot-internationalJanuary 24, 2023
336. Malhotra, Girish: Artificial Intelligence in Chemical Process Development, Manufacturing and Net Zero Profitability through Simplicity, March 31, 2023 The Hub Daily News CPHI North America, April 25-27, 2023
337. Malhotra, Girish: Art and Science of Chemical Process Development & Manufacturing Simplification University of Akron Chemical Engineering Senior Class April 11, 2023
338. Malhotra, Girish: Art and Science of Chemical Process Development & Manufacturing Simplification Cleveland State University Chemical Engineering Senior Class April 20, 2023
339. Malhotra, Girish: Should Pharmaceutical Product Quality EVEN be discussed in a public forum? Shouldn’t it be EXPECTED? Profitability through Simplicity, May 12, 2023
340. Malhotra, Girish: Art and Science of Chemical Process Development & Manufacturing Simplification https://www.aiche.org/ili/academy/webinars/art-and-science-chemical-process-development-manufacturing-simplification May 17, 2023
341. Malhotra, Girish: Capitalizing on Mutual Behavior and Chemical Reactivity of Chemicals, Profitability through Simplicity May 29, 2023
342. Malhotra, Girish: Chemicals tell us how to exploit their behavior for better processes. Clues are ignored. Should we? Profitability through Simplicity, June 20, 2023
343. Malhotra, Girish: Webinar “The History and Future of Pharmaceutical Industry – focus on small molecule drugs” Central Michigan University College of Medicine.
344. Malhotra, Girish: Considerations to have an excellent environmentally friendly and economic chemical process? Profitability through Simplicity, August 28, 2023
345. Malhotra, Girish: Marriage of Science and Technology in Active Pharmaceutical Ingredient (API) Manufacturing and their Formulations: Is it for real? Profitability through Simplicity, September 21, 2023
346. Malhotra, Girish: Roadmap to Reduce Drug Shortages and Bring Pharma Manufacturing Home (US) Profitability through Simplicity, October 30, 2023
347. Malhotra, Girish: USA’s Annual Ritual of Drug Sourcing/pricing and Shortages, Profitability through Simplicity November 25, 2023
348. Malhotra, Girish: Manufacturing Technology Innovations in Pharmaceutical Manufacturing: Profitability through Simplicity, February 23, 2024
349. Malhotra, Girish: Use of Tradition, Creativity, Imagination and Technology Innovation in Propofol Manufacturing Profitability through Simplicity, March 21, 2024
350. Malhotra, Girish: Use of Tradition, Creativity, Imagination and Technology Innovation in Propofol Manufacturing Profitability through Simplicity, April 4, 2024
351. Malhotra, Girish: USP 11,267,798 B2: Manufacture of Piperine (1) An Excellent Teaching Tool Profitability through Simplicity, June 17, 2024
352. Malhotra, Girish: Process Simplification and Net Zero: Capitalizing on Physical and Chemical Properties of Reactants and Intermediate, Profitability through Simplicity, August 20, 2024
353. Malhotra, Girish: Environmental Conservation (Green Chemistry, Net Zero, Decarbonizing) in Active Pharmaceutical Ingredients (APIs) & Fine/Specialty Chemical Manufacturing, Profitability through Simplicity, October 2, 2024
354. Malhotra, Girish: Net Zero for Active Pharmaceutical Ingredient & Fine/Specialty Chemicals: Non Destructive Creations, Profitability through Simplicity, November 7, 2024
355. Malhotra, Girish: Process Simplification: Is the Best Answer: New Terminologies or the Application of Fundamentals? Profitability through Simplicity December 14, 2024
356. Malhotra, Girish: An Update: Artificial intelligence in Pharmaceutical/Chemical Process Development, Manufacturing & Net Zero [Post of March, 31, 2023], Profitability through Simplicity, February 14, 2025
357. Malhotra, Girish: Sociochemicology: Redefining Chemical Process Design for Efficiency and Sustainability, Profitability through Simplicity, February 26, 2025
358. Malhotra, Girish: Net Zero for APIs, Specialty Chemical Magazine March/April 2025 pg. 24-26
359. Malhotra, Girish: Remedy of US’s Drug Supply Chain Shortages and Domestic Production of Generic and Brand Drugs, Profitability through Simplicity, April 15, 2025
360. Malhotra, Girish: An Outlier Plan to Bring Pharmaceutical Manufacturing to USA in One Year, Profitability through Simplicity, April 28, 2025
361. Malhotra, Girish: Implementing Executive Orders on Domestic Production of Critical Medicines and Achieve Most Favored Nation Pricing, Profitability through Simplicity, June 11, 2025
362. Malhotra, Girish: An Unconventional Analysis: Can the Wrath of Most Favored Nation Pricing (1) be Avoided by Bringing Pharmaceutical Product & Process Development and Manufacturing Practices to 21st Century? Profitability through Simplicity, July 8, 2025
363. Malhotra, Girish: Most Favored Nation Pricing & Bringing Pharmaceutical Manufacturing Home, Profitability through Simplicity, July 13, 2025
364. Malhotra, Girish: Executive Order 14293 & FDA Processes, Profitability through Simplicity, August 8, 2025
365. Malhotra, Girish: Physical Properties of Chemicals, their Mutual Behavior i.e. SOCIOCHEMICILOGY and Process Simplification, Profitability through Simplicity, September 8, 2025
366. Malhotra, Girish: Let us "THINK DIFFERENTLY'. It is time especially for pharmaceuticals, Profitability thorough Simplicity, September 23, 2025
367. Malhotra, Girish: FDA’s ANDA Prioritization Pilot and Possibilities of its Success, Profitability through Simplicity October 7, 2025
368. Malhotra, Girish: For Domestic Pharma Manufacturing: Reorganize CDER, Profitability through Simplicity, November 6, 2025
369. Malhotra, Girish: Revised UPDATE: US Domestic Generic Pharma Manufacturing needs Shorter Approval Time and Lower ANDA Fee, Profitability through Simplicity, December 18, 2025
370. Malhotra, Girish: Imagination, Creativity and Sociochemicology (1) in Chemical Process Development, Profitability through Simplicity, January 10, 2026
371. Malhotra, Girish: SOCIOCHEMICOLOGY: Designing Chemical Processes by Exploiting the Social Behavior of Molecules, Profitability through Simplicity, February 22, 2026
372. Malhotra, Girish: The Process Development Triumvirate: Profitability Through Simplicity, Profitability through SimplicityMarch 24, 2026
373. Malhotra, Girish: Exploitation and Capitalization of Mutual Behavior of Chemicals (Sociochemicology) and Process Equipment for the Manufacture of Propofol, Profitability through Simplicity, May 5, 2026
374. Malhotra, Girish: Sociochemicology: Its Birth and Value, Profitability through Simplicity, June 29, 2026
375. Malhotra, Girish: Role of Village and Triumvirate in Process Development of Isoniazid :- a Tuberculosis Drug, Profitability through Simplicity, September 29, 2026
AWARDS AND HONORS Sherwin Williams Co. President’s Cost Reduction Awards 1979 and 1982
PROFESSIONAL ASSOCIATION MEMBERSHIPS AND AFFILIATIONS
· Member Advisory Board TwoFour Insight Group LLC. January 2014- May 2016
· Member Scientific Advisory Board chemica oggi Chemistry Today 2014 - 2017
· Online Advisory Board Chemical & Engineering News American Chemical Society (2102-2015)
· Editorial Advisory Board Pharmaceutical Processing Magazine 2006- 2020
· Editorial Advisory Board Pharmaceutical Manufacturing Magazine 2010- Present
· Editorial Advisory Board www.pharmaqbd.com 2011- 2017
· Member CPhI Worldwide Expert Industry Panel 2013-2021
· Judge CPhI Awards panel 2016, 2017, 2018
· Editorial Advisory Board GMPNEWS.NET 2019-2022
· Ask the Expert “Process Simplification” Chemical Processing Magazine
· Ask the Expert “API Manufacturing” Pharmaceutical Manufacturing Magazine
· Registered Professional Engineer in States of Illinois (73-Present) and Ohio (76-present)
· Association of Consulting Chemists and Chemical Engineers 1996-2018
· American Institute of Chemical Engineers 1967 - Present
· Bemis Co. Rep - Industrial Research Institute ‘91-’96
· Toastmasters ’94-’98
· Who’s Who Member: Chemical Engineering Product Research Panel 1975-1977
EDUCATION AND TRAINING
· MBA Program; Xavier University - Cincinnati, OH; 1977-1979
· M. S. Chemical Engineering; Clarkson University - Potsdam, NY; 1968 (Thesis: Effect of pulsations on laminar flow in porous conduits)
· Graduate Diploma; Petroleum Refining; Indian Institute of Petroleum – India, 1966
· B. S. Chemical Engineering; Harcourt Butler Technological Institute – India, 1965 Seminars in: Drug delivery systems, radiation curing, pressure sensitive and release technologies, technology management, digital imaging, and crystallization
COMMUNITY AND PERSONAL ACTIVITIES
· Junior achievement counselor
· CPR trainer
· Judge Intel International Science and Engineering Fair 2003, Cleveland, OH
· Member Community Emergency Response Team 2021 -present
· Holden Arboretum 2018- 2021
· Mentor College Now 2020-2029
· Mentor True2U 2019
· Member Rotary Club of Chagrin Highlands 2019 - present